Navigation Links
Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation
Date:7/29/2008

. SPECT measures regional cerebral blood flow (rCBF) which is closely related to brain cell activity. The study showed that treatment with MTC at the 60mg dose eliminated the rCBF decline that was seen in control subjects. The effect was greatest in brain regions that had the most severe tau aggregation pathology, namely the hippocampus and the entorhinal cortex, which are regions affected early and most severely in Alzheimer's.

"This is the first instance of a disease-modifying Alzheimer's therapy that has attained its primary, pre-specified cognitive efficacy target in a clinical trial," said Wischik. "This trial therefore provides the first clinical trial evidence that an Alzheimer's therapy aimed at blocking tau aggregation may be a viable disease-modifying treatment. We now need to confirm this in a larger Phase III trial."

"Our results appear to meet the draft EMEA clinical guidelines for disease-modifying therapy, supported by SPECT and PET evidence of efficacy in brain regions heavily affected by tau pathology," Wischik added.

Proof of Concept Clinical Trial of Souvenaid(TM): A Medical Nutrition Approach to Mild Alzheimer's

People with Alzheimer's exhibit a significant loss of brain synapses, and this loss correlates with the loss of cognitive function. Pre-clinical research using a technique invented by Massachusetts Institute of Technology (MIT) has shown that specific combinations of nutrients can increase synapse formation. Now a double-blind, controlled study with Souvenaid(TM), including these nutrients, has shown it may help patients with mild Alzheimer's Disease.

Souvenaid(TM), developed by Danone Research - Centre for Specialised Nutrition, is designed to improve synapse formation and synaptic transmission via the synergistic action of a combination of nutrients (specifically, it contains uridine monophosphate, choline, the omega-3 fatty acids (EPA, DHA), phospholipids, B vitamins and antioxidants). Pre-clinical re
'/>"/>

SOURCE Alzheimer's Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
2. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation
5. Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials
6. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
7. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
8. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
9. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
10. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
11. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015  Intec Pharma Ltd. (the ... company focused on developing drugs based on its proprietary ... its initial public offering in the United ... at a price to the public of $6.00 per ... the ordinary shares are being offered by the Company.  ...
(Date:8/4/2015)... Aug. 4, 2015 Concord Medical Services Holdings Limited ... hospital management solution provider and operator of the largest network ... , today announced it will release its financial results ... on August 17, 2015. Management will hold a ... 8:00 a.m. EDT on August 18, 2015 (8:00 p.m. in ...
(Date:8/4/2015)... 4, 2015 BioElectronics Corporation (OTC Pink: ... Pain Therapy medical devices, announced today that its ... 7-day trial device has been published in the ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic ... an assessment.  Chronic pain is ...
Breaking Medicine Technology:Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2
... WASHINGTON, Oct. 8 As Congress wraps up work ... of Transplantation,s (AST) Public Policy Committee arrived on Capitol ... health care provision that would ensure kidney transplant recipients ... The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients ...
... Adnavance Technologies Inc., a developer of direct detection ... Randy White, Ph.D. chief executive officer, will present initial ... clinical samples during company presentations at the following conferences: ... at 10:00 a.m. Eastern Time at the Walter E. ...
Cached Medicine Technology:AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform 2Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference 2
(Date:8/4/2015)... ... 04, 2015 , ... PerceptiMed, Inc. announces the addition of ... to its Board of Directors effective August 1, 2015. , "PerceptiMed's proprietary ... strongly believe in the mission of the company and the capabilities of Dr. ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... and other international locations have shown a rise in binge drinking among certain ... between binge drinking and depression, are continuing to examine trends and evidence to ...
(Date:8/4/2015)... ... August 04, 2015 , ... 24/7 Care At Home , a provider ... Bernardino, today announced that the U.S. Department of Veteran’s Affairs (VA) has awarded its ... agency is well on the path to meeting the aspirational goals the VA promotes ...
(Date:8/4/2015)... ... August 04, 2015 , ... Discovia, a leading ... announced that John Munro, a 15-year veteran of the eDiscovery services industry, has ... , “I am thrilled to join Discovia at this important point in its ...
(Date:8/4/2015)... ... August 04, 2015 , ... Mesothelioma researchers in Australia ... Retreatment may be a viable option. Surviving Mesothelioma has just posted an article ... to surgeons at the University of New South Wales, peritoneal mesothelioma patients ...
Breaking Medicine News(10 mins):Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:24/7 Care At Home Receives Two Stars from the VA 2Health News:24/7 Care At Home Receives Two Stars from the VA 3Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 3Health News:New Research Reveals Some Patients Experience Extended Mesothelioma Survival with Repeat Treatment, According to Surviving Mesothelioma 2
... ... boon to the diagnostic lab industry in the form of new business, but downward pressure ... Dennis Weissman at a Slone Partners teleconference on the new law April 21. , ... Miami, FL (PRWEB) May 4, 2010 ...
... ... can now benefit from having critical documents e-Notarized by David Walsh, Solicitor and Notary ... Portsmouth, ... the longest established Certification Authorities (CA) and specialists in digital certificate security, has today ...
... , ... its hugely successful interactive free online counselling Forum, Myeexpert in partnership with Strategic Insight ... about book, titled: “Poetic Expressions: For Healing, Healthy Living and Relationships. , ... (PRWEB) May 4, 2010 -- Quoting verses ...
... ... as Ohio Super Lawyers®. This honor, by the much respected Ohio Super Lawyers® magazine, recognizes ... , ... May 4, 2010 -- Spangenberg lawyers were again honored this year when six of their ...
... ... this bathroom plunger virtually bacteria free. , ... (PRWEB) May 4, 2010 -- Ross Nanotechnology Corporation presents NeverWet™, ... water. Its first product is the Clear-n-Clean Plunger . Unlike traditional plungers, the ...
... ... urging students and job seekers to explore the water sector to discover careers that are ... ... -- As Drinking Water Week continues, the American Water Works Association (AWWA) is ...
Cached Medicine News:Health News:Lab Industry Likely to Benefit from Expanded Preventive Testing Under New Health Care Law 2Health News:Lab Industry Likely to Benefit from Expanded Preventive Testing Under New Health Care Law 3Health News:GlobalSign Announces First Successful E-Notarization in Ireland 2Health News:GlobalSign Announces First Successful E-Notarization in Ireland 3Health News:GlobalSign Announces First Successful E-Notarization in Ireland 4Health News:“You Are Very Pretty”, Says Myeexpert As It Releases A Book, Poetic Expressions, Dedicated To The Beauty of Women. 2Health News:Cleveland Attorneys Recognized as Ohio Super Lawyers on 2010 List 2Health News:Cleveland Attorneys Recognized as Ohio Super Lawyers on 2010 List 3Health News:Ross Nanotechnology Corporation Introduces the NeverWet™ Coating on its First Consumer Product – The Clear-n-Clean Plunger 2Health News:During Drinking Water Week 2010, Water Sector Urges Students, Job Seekers to Work for Water 2
... new Eclipse TS-100 is an innovative ... high quality tool complements any research ... CFI60 optics offer brilliant, sharp ... superb optical performance with high resolution ...
... Nikon Instruments Inc., a world leader ... the introduction of its new Universal ... Nikon Eclipse upright microscope models, including ... This Universal Epi Illuminator provides ...
... monochrome digital CCD camera ideal for demanding low-light ... high-resolution images with outstanding clarity and detail. ... Live Image Frame Rate - ... 170x120 (8x8) Image Display Speed ...
... Sonys new DFW-SX910 digital camera is ... CCD with square pixels and offers excellent ... resolution). This camera delivers uncompressed, ... easy-to-use asynchronous electronic shutter function with an ...
Medicine Products: